Skip to content

Choroid In Coronary Artery Disease

Choroid Thickness May Shed Light On Early Coronary Artery Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06442176
Enrollment
128
Registered
2024-06-04
Start date
2021-03-01
Completion date
2024-04-21
Last updated
2024-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroid Diseases

Keywords

Coronary Artery Disease, Choroid, Gensini Score, Optical Coherence Tomography

Brief summary

Purpose: To investigate any relationship between choroid thickness (CTh) and coronary artery disease (CAD), particularly in its earlier stages before clinically evident. Design: Retrospective, cross-sectional observational study Methods: Setting: The study was performed in two institutions; patients were recruited in Balikesir City Hospital. The ophthalmological examinations and coronary angiograms were performed in Balikesir City Hospital. The analysis of the coronary angiograms including Gensini scoring were conducted in Bursa Education and Research Hospital. Study Population: The study group comprised 68 patients with documented CAD and 60 healthy control subjects. Patients with high myopia, cataracts, retinal vascular disease, retinal surgery, retinal dystrophy, laser photocoagulation, intravitreal anti-VEGF treatment, glaucoma, uveitis, retinal disorders, any systemic diseases were excluded from the study groups. Observation Procedure: Refractive examination, corrected visual acuity, intraocular pressure measurements, anterior and posterior segment examinations. Following measurements of macular thickness and retinal nerve fiber layer, choroidal thickness of both eyes was assessed by enhanced depth imaging optical coherence tomography.

Interventions

DIAGNOSTIC_TESTOCT

Enhanced depth imaging optical coherence tomography (EDI-OCT) using the Heidelberg Spectralis HRA + OCT (Heidelberg Engineering, Inc., Franklin, MA, USA)

Sponsors

Bursa Yuksek Ihtisas Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Normal coronaries at coronary angiography for healthy control group * Without any coronary artery disease equivalent diseases such as peripheral artery disease, cerebrovascular disease and stroke for healthy control group * Ability to give informed consent for the study * Coronary artery disease with stenosis detected in coronary angiogram for coronary artery disease group

Exclusion criteria

* High myopia (\> 6D) * Cataracts * Retinal vascular disease * Retinal surgery * Retinal dystrophy * Laser photocoagulation * Intravitreal anti-VEGF treatment * Glaucoma * Uveitis * Retinal disorders (comprising diabetic macular edema, diabetic/hypertensive retinopathy, vein occlusions, retinal dystrophy, epiretinal membrane, vitreomacular traction, age-related macular degeneration) * Any systemic diseases * Obesity (body-mass index ≥30 kg/m²)

Design outcomes

Primary

MeasureTime frameDescription
Choroidal thickness in Healthy Subjects1 daymicron
Choroidal thickness in patients with coronary artery disease1 daymicron

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026